Nuvectis Pharma (NVCT)
24.49
+0.12 (0.49%)
Upcoming Events
Latest Headlines
Nuvectis Pharma To Participate in Upcoming Investor Conferences
September 3, 2026 8:00 AM - StreetInsider
Lucid Capital Markets Assumes Nuvectis Pharma (NVCT) at Buy
September 1, 2026 6:12 AM - StreetInsider
Cantor Fitzgerald Starts Nuvectis Pharma (NVCT) at Overweight
August 24, 2026 6:19 AM - StreetInsider
Nuvectis Pharma (NVCT) files $200M mixed shelf
August 21, 2026 4:41 PM - StreetInsider
Form S-3 Nuvectis Pharma, Inc.
August 21, 2026 4:38 PM - SEC Filing
Form 8-K Nuvectis Pharma, Inc. For: Jul 20
August 21, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G Nuvectis Pharma, Inc. Filed by: Soleus Private Equity Fund III, L.P.
August 6, 2026 11:29 AM - SEC Filing
Form 4 Nuvectis Pharma, Inc. For: Aug 03 Filed by: Carson Michael J.
August 5, 2026 5:26 PM - SEC Filing
Form 10-Q Nuvectis Pharma, Inc. For: Jun 30
August 4, 2026 9:02 AM - SEC Filing
Form 8-K Nuvectis Pharma, Inc. For: Aug 04
August 4, 2026 8:25 AM - SEC Filing
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
August 4, 2026 8:01 AM - Globe NewsWire
Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 23, 2026 9:00 AM - StreetInsider
China approves Nuvectis drug ciprocopan for PNH treatment
July 23, 2026 7:30 AM - StreetInsider
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
July 23, 2026 7:30 AM - StreetInsider
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
July 14, 2026 10:42 AM - StreetInsider
Form 4 Nuvectis Pharma, Inc. For: Jun 30 Filed by: Mosseri Marlio Charles
July 1, 2026 1:42 PM - SEC Filing
Form 4 Nuvectis Pharma, Inc. For: Jun 30 Filed by: BENTSUR RON
July 1, 2026 1:40 PM - SEC Filing
Form 8-K Nuvectis Pharma, Inc. For: Jun 29
June 30, 2026 4:43 PM - SEC Filing
Form 424B5 Nuvectis Pharma, Inc.
June 30, 2026 4:42 PM - SEC Filing
Nuvectis Pharma prices $100M public offering at $20 per share
June 29, 2026 10:30 PM - StreetInsider
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
June 29, 2026 10:30 PM - Globe NewsWire
Form 424B5 Nuvectis Pharma, Inc.
June 29, 2026 4:32 PM - SEC Filing
Form 8-K Nuvectis Pharma, Inc. For: Jun 29
June 29, 2026 4:08 PM - SEC Filing
Nuvectis Pharma launches public stock offering via Cantor
June 29, 2026 4:01 PM - StreetInsider
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
June 29, 2026 4:01 PM - StreetInsider
Form 8-K Nuvectis Pharma, Inc. For: Jun 22
June 23, 2026 7:01 AM - SEC Filing
Nuvectis Pharma (NVCT) PT Raised to $39 at H.C. Wainwright
June 23, 2026 6:53 AM - StreetInsider
Nuvectis licenses two clinical-stage compounds from Haisco
June 22, 2026 7:30 AM - StreetInsider
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
June 22, 2026 7:30 AM - StreetInsider
Form 4 Nuvectis Pharma, Inc. For: Jun 11 Filed by: Hoberman Kenneth
June 12, 2026 4:13 PM - SEC Filing
Form 4 Nuvectis Pharma, Inc. For: Jun 11 Filed by: Oliviero James F III
June 12, 2026 4:12 PM - SEC Filing
Form 4 Nuvectis Pharma, Inc. For: Jun 11 Filed by: Sanchez Juan
June 12, 2026 4:12 PM - SEC Filing
Form 4 Nuvectis Pharma, Inc. For: Jun 11 Filed by: Kaplan Matthew L.
June 12, 2026 4:11 PM - SEC Filing
Form 8-K Nuvectis Pharma, Inc. For: Jun 11
June 12, 2026 4:06 PM - SEC Filing
Full Article List
